Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

18F-FDG PET/CT for Detection of Metastatic Infection in Gram-Positive Bacteremia

Fidel J. Vos, Chantal P. Bleeker-Rovers, Patrick D. Sturm, Paul F.M. Krabbe, Arie P.J. van Dijk, Maria L.H. Cuijpers, Eddy M.M. Adang, Geert J.A. Wanten, Bart-Jan Kullberg and Wim J.G. Oyen
Journal of Nuclear Medicine August 2010, 51 (8) 1234-1240; DOI: https://doi.org/10.2967/jnumed.109.072371
Fidel J. Vos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chantal P. Bleeker-Rovers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick D. Sturm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul F.M. Krabbe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arie P.J. van Dijk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria L.H. Cuijpers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eddy M.M. Adang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geert J.A. Wanten
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bart-Jan Kullberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim J.G. Oyen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Enrollment of prospectively included study patients and historical control patients from database of Department of Medical Microbiology. False-positive 18F-FDG PET/CT scan results were found in 7 patients. Localized colonic uptake, followed by normal colonoscopy results, was seen in 2 patients. In 1 patient, shoulder uptake was not accompanied by hydrops on ultrasound, but no puncture was performed. Confirmed mediastinal lymphadenopathy on CT was seen in 1 patient, but no further diagnostic tests were performed. Lymphadenopathy had disappeared after 6 mo of follow-up. Pleural uptake without pleural effusion on chest radiography was seen in 1 patient. She died before further investigations could be performed. In 1 patient, uptake in psoas was thought to be due to recent bleeding seen on CT. No cultures were taken in this patient, and she was treated for 6 mo because of infected knee prosthesis. Abnormalities on CT disappeared. In 1 patient, 18F-FDG uptake was present at site of pacemaker lead. He refused transesophageal echocardiography and was treated for 6 wk until presumed infected kidney stone was removed. Infection did not recur.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    18F-FDG PET/CT of patient with community-acquired S. aureus bacteremia and proven endocarditis, presenting with fever, heart failure, and new cardiac murmur (aortic valve insufficiency). 18F-FDG PET/CT detected accumulation in left common iliac artery (arrow) due to clinically silent mycotic aneurysm. This finding resulted in prolonged treatment with antibiotics and monitoring of aneurysm size. Coronal sections are shown for 18F-FDG PET (A), CT (B), and integrated 18F-FDG PET/CT (C).

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Kaplan–Meier curve for survival at 6-mo follow-up in study and control groups.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Kaplan–Meier curves for duration of treatment. (A) Duration of treatment between study and control groups when metastatic foci were present. (B) Duration of treatment between study and control group when metastatic foci were absent.

Tables

  • Figures
    • View popup
    TABLE 1.

    Baseline Characteristics of Study Patients and Historical Controls

    ParameterStudy patients (n = 115)Controls (n = 230)P
    Male56%52%0.57
    Mean age ± SD (y)59 ± 1658 ± 16
    Matching criteria
     S. aureusn = 73 (64)n = 146 (64)1.0
     Streptococcus speciesn = 30 (26)n = 60 (26)1.0
     Enterococcus speciesn = 12 (10)n = 24 (10)1.0
    Community acquisition70%68%0.71
    Additional risk factors
     Treatment delay27%45%0.01
     Persistent fever46%37%0.13
     Remaining possible risk factors
     Portal of entry unknown52%46%0.30
     Central venous catheter not removed within 48 h5%8%0.50
     Persistent positive blood cultures16%6%*0.006
     Immune suppression22%17%0.30
    • ↵* Not routinely obtained in control group.

    • Data presented in parentheses are percentages.

    • View popup
    TABLE 2.

    Localization of Metastatic Foci and Number of Foci First Detected by 18F-FDG PET/CT

    Study patients (n = 115)Controls (n = 230)
    Metastatic fociTotal number%First detected by 18F-FDG PETTotal number%P
    Patients with foci identified7867.88235.7<0.01
    Total number of foci124113
    Endocarditis2118.30198.30.01
    Endovascular2017.41293.9<0.01
    Lung1210.4683.50.01
    Liver10.9010.41.0
    Spleen10.91001.0
    Arthritis108.732812.20.37
    Spondylodiskitis119.68104.30.09
    Osteomyelitis65.2131.30.06
    Psoas abscess32.6210.40.11
    Soft tissue119.64125.20.18
    Central nervous system119.63*73.00.02
    Eye32.600*00.04
    Joint prosthesis97.8352.20.02
    Intraabdominal43.5162.60.74
    Kidney10.9041.70.67
    • ↵* Epidural extension of 18F-FDG uptake in 3 patients with spondylodiskitis, confirmed by MRI.

    • In 30 study patients and 22 controls, more than 1 metastatic localization was identified.

    • View popup
    TABLE 3.

    Clinical Endpoints at 3- and 6-Month Follow-up

    Follow-up intervalStudy patientsControlsP
    3 mo
     Total115230
     Cure72 (62.6)151 (65.6)0.63
     Relapse3 (2.6)17 (7.4)0.09
     Persisting infection21 (18.2)3 (1.3)0.001
     Mortality19 (16.6)59 (25.7)0.06
     Relapse in S. aureus subgroup1/73 (1.4)13/146 (8.9)0.04
    6 mo*
     Total115230
     Cure83 (72.2)154 (66.9)0.26
     Persisting infection8 (7)0<0.001
     Overall mortality22 (19.1)74 (32.2)0.007
     Infection-related mortality17 (14.8)56 (24.3)0.049
     Lost to follow-up2 (1.7)2 (0.9)0.60
    • ↵* At 6-mo follow-up, 8 patients had died after relapse of infection in control group vs. 2 in study group.

    • Data presented in parentheses are percentages. P values are estimated by Fisher exact tests.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 51 (8)
Journal of Nuclear Medicine
Vol. 51, Issue 8
August 1, 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FDG PET/CT for Detection of Metastatic Infection in Gram-Positive Bacteremia
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-FDG PET/CT for Detection of Metastatic Infection in Gram-Positive Bacteremia
Fidel J. Vos, Chantal P. Bleeker-Rovers, Patrick D. Sturm, Paul F.M. Krabbe, Arie P.J. van Dijk, Maria L.H. Cuijpers, Eddy M.M. Adang, Geert J.A. Wanten, Bart-Jan Kullberg, Wim J.G. Oyen
Journal of Nuclear Medicine Aug 2010, 51 (8) 1234-1240; DOI: 10.2967/jnumed.109.072371

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FDG PET/CT for Detection of Metastatic Infection in Gram-Positive Bacteremia
Fidel J. Vos, Chantal P. Bleeker-Rovers, Patrick D. Sturm, Paul F.M. Krabbe, Arie P.J. van Dijk, Maria L.H. Cuijpers, Eddy M.M. Adang, Geert J.A. Wanten, Bart-Jan Kullberg, Wim J.G. Oyen
Journal of Nuclear Medicine Aug 2010, 51 (8) 1234-1240; DOI: 10.2967/jnumed.109.072371
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Importance of Blood Glucose Management Before 18F-FDG PET/CT in 322 Patients with Bacteremia of Unknown Origin
  • Sterile endogenous panophthalmitis with uncontrolled diabetes
  • 18F-FDG PET/CT-Guided Treatment Duration in Patients with High-Risk Staphylococcus Aureus Bacteremia: A Proof of Principle
  • The Value of 18F-FDG PET/CT in Diagnosis and During Follow-up in 273 Patients with Chronic Q Fever
  • 18F-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality
  • Characterization of 18F-Fluorodeoxyglucose Uptake Pattern in Noninfected Prosthetic Heart Valves
  • Clinical Usefulness of 18F-FDG PET/CT for the Detection of Infections of Unknown Origin in Patients Undergoing Maintenance Hemodialysis
  • 18F-FDG PET/CT for the Detection of Septic Embolisms in Patients with Infectious Endocarditis
  • Role of 18F-FDG PET in Patients with Infectious Endocarditis
  • Imaging of Inflammation by PET, Conventional Scintigraphy, and Other Imaging Techniques
  • EANM/SNMMI Guideline for 18F-FDG Use in Inflammation and Infection
  • Cost-Effectiveness of Routine 18F-FDG PET/CT in High-Risk Patients with Gram-Positive Bacteremia
  • Nuclear Medicine Imaging of Infection in Cancer Patients (With Emphasis on FDG-PET)
  • Imaging of Inflammation by PET, Conventional Scintigraphy, and Other Imaging Techniques
  • Google Scholar

More in this TOC Section

  • First-in-Human Study of 18F-Labeled PET Tracer for Glutamate AMPA Receptor [18F]K-40: A Derivative of [11C]K-2
  • Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy Analysis
  • [11C]Carfentanil PET Whole-Body Imaging of μ-Opioid Receptors: A First in-Human Study
Show more Clinical Investigation

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire